Skip to main content
Not Found
Multiday Session Course

Clozapine Bootcamp: Why, When and How to Use this Evidence Based Treatment

Total Credits: 30.25 including 30.25 Category II CEs

Categories:
OnDemand
Instructors:
Deanna Kelly, PharmD, BCPP |  Robert W. Buchanan, M.D. |  Robert W. Buchanan, M.D. |  Gopal Vyas, DO |  Gopal Vyas, DO |  Gopal Vyas, DO |  Megan Ehret, PharmD, MS, BCPP |  Fred Nucifora, Ph.D., D.O., M.H.S |  Gopal Vyas, DO |  Megan Ehret, PharmD, MS, BCPP |  Gopal Vyas, DO |  Ikwunga Wonodi, M.D., M.B.A |   13 more....
Save for Later  Add to Cart »

Description

You have 8 months (from purchase) to access the recordings and complete the quizzes. 

This comprehensive, asynchronous program on clozapine covers its efficacy, effectiveness, and use in treating schizophrenia and related disorders, including its risk-to-benefit profile and off-label applications. Participants will learn about clozapine's pharmacology, mechanism of action, and treatment guidelines, as well as how to identify treatment-resistant schizophrenia and manage its challenges. The sessions delve into practical aspects such as dosing, titration, and monitoring for hematologic side effects like neutropenia. Additional topics include managing specific side effects such as constipation, tachycardia, and seizures, as well as addressing clozapine's use in African American patients, young patients, and those with medical comorbidities. The program also emphasizes effective communication with patients and families, managing drug interactions, and exploring augmentation strategies. Through didactic overviews and expert discussions, participants gain a thorough understanding of clozapine's clinical use, potential complications, and best practices for optimizing treatment outcomes.

Learning Objectives

Upon the completion of this workshops, participants will be able to: 

Describe the efficacy and effectiveness of clozapine in psychotic disorders

· Compare the efficacy and effectiveness of clozapine with other antipsychotic medications

· Analyze the risk to benefit considerations of clozapine use

· List some off-label uses for clozapine

Target Audience

Social Workers, LCPCs, and Psychologists

We welcome anyone interested in the topic!

 

Webinar Policies & FAQs

Click The Link to View The Webinar Policies & FAQs

https://umbsswcpe.ce21.com/Page/live-interactive-webinar-procedures-policies-4129

 

 

ADA Accommodations

If you are requesting ADA accommodations, please contact our office via email at least two weeks prior to the workshop date. Requests after that date may not be fulfilled.  

Our email address is cpe@ssw.umaryland.edu.  

Availability Module Title Speaker Credits Course Type Duration Course Details
At the time of purchase Part 1: Efficacy and Effectiveness of Clozapine in Schizophrenia Related Disorders, Risk to Benefit Considerations and Off-Label Use
Deanna Kelly, PharmD, BCPP Robert Buchanan, M.D. Gopal Vyas, DO
Total Credits: 4.5 including 4.5 Category II CEs On Demand 4 Hours 36 Minutes More info »
At the time of purchase Part 2: Pharmacology, Mechanism of Action of Clozapine, and Treatment Guidelines
Gopal Vyas, DO Deanna Kelly, PharmD, BCPP
Total Credits: 5.75 including 5.75 Category II CEs On Demand 5 Hours 54 Minutes More info »
At the time of purchase Part 3: How to Determine if Someone has Treatment-Resistant Schizophrenia
Robert W. Buchanan, M.D. Gopal Vyas, DO Megan Ehret, PharmD, MS, BCPP
Total Credits: 4.5 including 4.5 Category II CEs On Demand 4 Hours 36 Minutes More info »
At the time of purchase Part 4: Barriers to Clozapine Use and Tips for Implementation of Clozapine Use in Team-Based Settings
Fred Nucifora, Ph.D., D.O., M.H.S Gopal Vyas, DO Megan Ehret, PharmD, MS, BCPP
Total Credits: 3.5 including 3.5 Category II CEs On Demand 3 Hours 34 Minutes More info »
At the time of purchase Part 5: Contraindications to Clozapine and Pre-clozapine Workup/Initiation Guidance
Gopal Vyas, DO Ikwunga Wonodi, M.D., M.B.A Fred Nucifora, Ph.D., D.O., M.H.S
Total Credits: 3.75 including 3.75 Category II CEs On Demand 3 Hours 57 Minutes More info »
At the time of purchase Part 6: Dosing and Titration of Clozapine
Fred Nucifora, Ph.D., D.O., M.H.S Gloria Reeves, MD Heidi Wehring, PharmD
Total Credits: 2 including 2 Category II CEs On Demand 2 Hours 09 Minutes More info »
At the time of purchase Part 7: Clozapine and Hematologic Monitoring: Focus on Neutropenia and Use of Point of Care Monitoring Device
Gopal Vyas, DO Fred Nucifora, D.O., M.H.S., Ph.D.,
Total Credits: 2.25 including 2.25 Category II CEs On Demand 2 Hours 25 Minutes More info »
At the time of purchase Part 8: How and When to Use Clozapine Blood Levels
Jonathan Meyer, M.D. Fred Nucifora, D.O., M.H.S, Ph.D. Megan Ehret, PharmD, MS, BCPP
Total Credits: 2 including 2 Category II CEs On Demand 2 Hours 12 Minutes More info »
At the time of purchase Part 9: Clozapine and Severe Neutropenia: Presentation, Treatment, Mechanism and Rechallenge
Megan Ehret, PharmD, MS, BCPP Marie Mackowick, Pharm.D., BCPP Deanna Kelly, PharmD., BCPP
Total Credits: 2 including 2 Category II CEs On Demand 2 Hours 18 Minutes More info »
Total Multiday Session Course CE Credits Information
Back to Top